Bruce D. Weintraub
Directeur Général chez Trophogen, Inc.
Postes actifs de Bruce D. Weintraub
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Trophogen, Inc.
 Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Directeur Général | 01/07/2001 | - |
| Fondateur | 25/02/2010 | - | |
| President | 01/07/2001 | - | |
| Directeur des opérations | 01/07/2001 | 21/01/2013 | |
| Directeur Technique/Scientifique/R&D | 01/07/2001 | 21/01/2013 |
Historique de carrière de Bruce D. Weintraub
Anciens postes connus de Bruce D. Weintraub
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Maryland | Corporate Officer/Principal | 01/01/1996 | 01/01/2001 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
| The Endocrine Society | Corporate Officer/Principal | - | - |
Formation de Bruce D. Weintraub
| Princeton University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
| The Endocrine Society |
- Bourse
- Insiders
- Bruce D. Weintraub
- Expérience
